Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families

被引:0
|
作者
Kirsi M. Määttä
Riikka Nurminen
Minna Kankuri-Tammilehto
Anne Kallioniemi
Satu-Leena Laasanen
Johanna Schleutker
机构
[1] University of Tampere,Institute of Biosciences and Medical Technology
[2] Fimlab Laboratories, BioMediTech
[3] Tampere University Hospital,Department of Clinical Genetics
[4] Turku University Hospital,Department of Pediatrics, Genetics Outpatient Clinic, and Department of Dermatology
[5] Tampere UniversityHospital,Department of Dermatology
[6] Tampere University Hospital,Institute of Biomedicine
[7] University of Turku,Department of Medical Genetics
[8] Turku University Hospital,undefined
来源
BMC Cancer | / 17卷
关键词
Breast cancer; Ovarian cancer; Germline;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families
    Maatta, Kirsi M.
    Nurminen, Riikka
    Kankuri-Tammilehto, Minna
    Kallioniemi, Anne
    Laasanen, Satu-Leena
    Schleutker, Johanna
    BMC CANCER, 2017, 17
  • [2] Hereditary breast and ovarian cancer
    Jacek Gronwald
    Tomasz Byrski
    Tomasz Huzarski
    Oleg Oszurek
    Anna Janicka
    Jolanta Szymańska-Pasternak
    Bohdan Górski
    Janusz Menkiszak
    Izabella Rzepka-Górska
    Jan Lubiński
    Hereditary Cancer in Clinical Practice, 6
  • [3] Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome
    Vicente, Rodrigo
    Costa, Diogo Alpuim
    Vitorino, Marina
    Mendes, Ana Duarte
    Santos, Catarina
    Fontes-Sousa, Mario
    CANCERS, 2022, 14 (19)
  • [4] Hereditary breast and ovarian cancer
    Sullcahuaman-Allende, Yasser
    Arias-Velasquez, Abelardo
    REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2008, 54 (03): : 194 - 198
  • [5] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Sabine Grill
    Juliane Ramser
    Heide Hellebrand
    Nicole Pfarr
    Melanie Boxberg
    Christine Brambs
    Nina Ditsch
    Alfons Meindl
    Eva Groß
    Thomas Meitinger
    Marion Kiechle
    Anne S. Quante
    Archives of Gynecology and Obstetrics, 2021, 303 : 1557 - 1567
  • [6] TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
    Grill, Sabine
    Ramser, Juliane
    Hellebrand, Heide
    Pfarr, Nicole
    Boxberg, Melanie
    Brambs, Christine
    Ditsch, Nina
    Meindl, Alfons
    Gross, Eva
    Meitinger, Thomas
    Kiechle, Marion
    Quante, Anne S.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2021, 303 (06) : 1557 - 1567
  • [7] Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia
    Konecny, Michal
    Milly, Miriam
    Zavodna, Katarina
    Weismanova, Eva
    Gregorova, Jaroslava
    Mlkva, Iveta
    Ilencikova, Denisa
    Kausitz, Juraj
    Bartosova, Zdena
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 119 - 130
  • [8] Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast–ovarian cancer families from Kerala, South India
    Vani Syamala
    Leelakumari Sreeja
    Volga S. Syamala
    B. Vinodkumar
    Praveenkumar B. Raveendran
    Hariharan Sreedharan
    Ratheesan Kuttappan
    Lekshmi Balakrishnan
    Ravindran Ankathil
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 867 - 874
  • [9] Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family
    Yang, Ciyu
    Arnold, Angela G.
    Trottier, Magan
    Sonoda, Yukio
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    Robson, Mark E.
    Stadler, Zsofia K.
    Walsh, Michael F.
    Hyman, David M.
    Offit, Kenneth
    Zhang, Liying
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (03) : 447 - 456
  • [10] Hereditary breast and ovarian cancer
    Lax, S. F.
    PATHOLOGE, 2017, 38 (03): : 149 - 155